Company news

PYC Therapeutics Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Retina Target Engagement Confirmed in Large Eye

September 29, 2021

Second Drug Program Progressing Towards Human Trials

June 8, 2021

March 2021 Quarterly Report and Cashflow

April 29, 2021

Lead Investigational Drug Demonstrates Key Improvement

March 1, 2021

Half Year Accounts and Appendix 4D

February 26, 2021

Progress US Clinical Stage Company and Corporate Objectives

February 21, 2021

Quarterly Activities Report and Appendix 4C

January 29, 2021

Visual Evidence of Lead Drugs Efficacy

December 15, 2020

Review of Activities and Appendix 4C

October 26, 2020

Successful Institutional Entitlement Offer and Placement

October 21, 2020

PYC Business and Equity Raising Presentation

October 19, 2020

PYC Equity Raising to Raise up to $55 Million

October 19, 2020

New Drug for Substantial Unmet Need Added to Pipeline

October 11, 2020

PYCs Lead Drug Effective in Patient Derived Models Tested

October 6, 2020

Second Potential Blockbuster Drug Added to PYCs Pipeline

October 4, 2020

Creation of Novel Gene Therapy Delivery Technology

September 7, 2020

Appendix 4E Preliminary Final Report

August 31, 2020

Executive re-structure across global operations

August 19, 2020

Shareholder Update - Forward View 2020 Milestones

August 4, 2020

June 2020 Quarterly Activity Report and Cashflow

July 30, 2020

Successful Dose Response & Toxicity Studies in Lead Program

July 21, 2020

S&P DJI Announces June 2020 Quarterly Rebalance

June 11, 2020

March 2020 Quarterly Activities and Cash Flow Report

April 29, 2020

Successful Efficacy Result on Path to First in Human Studies

March 31, 2020

Investor Presentation - February 2020

February 23, 2020

CEO Appointment and Establishment of US Office

February 12, 2020

Expansion Of Drug Development Pipeline

February 2, 2020

Appendix 4C - quarterly

January 31, 2020

Quarterly Shareholder Update

January 5, 2020

Drug Delivery Greater Than 100% More Effective In Animals

December 1, 2019

Conclusion of Genentech Antimicrobial Collaboration

November 14, 2019

Retail Offer Document

November 3, 2019

PYCs Institutional Entitlement Offer Closes

November 3, 2019

Entitlement Offer - Investor Presentation

October 31, 2019

$26.8m Fully Underwritten Accelerated Entitlement Offer

October 30, 2019

Sept 2019 Quarterly Shareholder Update and Appendix 4C

October 30, 2019

Successful Major Milestone - Human Retina in a Dish Models

October 8, 2019

Strategic Partnership and Lead Program

October 1, 2019

Successful Time-Course Studies in Animals

September 25, 2019

Successful Competitive Drug Evaluation in Animals

September 2, 2019

Successful Time - Course Studies in Animals

August 22, 2019

Response to ASX Aware Query

August 7, 2019

Phylogicas Technology is Effective in Human Cells

August 6, 2019

Company Presentation - July 2019

July 23, 2019

Operational Update and Appendix 4C

July 23, 2019

Animal Models - 400% Outperformance of Gold Standard

July 22, 2019

Break Through Animal Model Results

June 26, 2019

March 2019 Quarterly Operational Update and App4C

April 29, 2019

Collaboration Agreement - siRNA delivery

March 13, 2019

Flagship Program - Successful Animal Models

March 11, 2019

← Newer news releases · Older news releases →

Decks

The 5 newest of 99 decks. Every deck is listed under its year.